Fierce Pharma

With the ink barely dry on outgoing commissioner Marty Makary’s [...]

The company doubled sales of its Biogen-partnered Alzheimer’s disease treatment [...]

The U.S. Supreme Court has issued an emergency order, temporarily [...]

Despite a prolonged period of policy uncertainty in the U.S.—and [...]

As biologics have increasingly superseded small molecules in the biopharma [...]

Eli Lilly has made a six-year, $50 million commitment to [...]

Following an FDA approval in muscle-invasive bladder cancer patients who [...]

BeOne Medicines has entered the BCL-2 arena, securing an FDA [...]

As President Trump lands in Beijing, one major industry is [...]

Shortly after locking down its $4.8 billion deal for rare [...]